CD44v8-10 stabilizes a cystine-glutamate transporter, xCT, in the plasma membrane of cancer cells, resulting in the promotion of glutathione synthesis and the GSH-dependent antioxidant system in cancer cells [73]. Here, SLC7A11 is linked to cancer.